In situ cancer vaccination: An IL-12 defective vector/replication- competent herpes simplex virus combination induces local and systemic antitumor activity

Masahiro Toda, Robert L. Martuza, Hidefumi Kojima, Samuel D. Rabkin

Research output: Contribution to journalArticlepeer-review

140 Citations (Scopus)

Fingerprint

Dive into the research topics of 'In situ cancer vaccination: An IL-12 defective vector/replication- competent herpes simplex virus combination induces local and systemic antitumor activity'. Together they form a unique fingerprint.

Medicine & Life Sciences